Caveats of mesenchymal stem cell therapy in solid organ transplantation
Cardiovascular morbidity and mortality after kidney transplantation
How can we minimize bleeding complications in ABO-incompatible kidney transplant recipients? *
ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption
Primary preventive cardioverter-defibrillator implantation (Pro-ICD) in patients awaiting heart transplantation. A prospective, randomized, controlled 12-year follow-up study
Renal function three years after early conversion from a calcineurin inhibitor to everolimus: results from a randomized trial in kidney transplantation
Prognostic value of enzymatic liver function for the estimation of short-term survival of liver transplant candidates: a prospective study with the LiMAx test
The effect of bright light therapy on sleep and circadian rhythms in renal transplant recipients: a pilot randomized, multicentre wait-list controlled trial
Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy
Metabolic syndrome definitions and components in predicting major adverse cardiovascular events after kidney transplantation
Magnetic ring anastomosis of suprahepatic vena cava: novel technique for liver transplantation in rat
Adaptive and innate immune responses in a rat orthotopic lung transplant model of chronic lung allograft dysfunction
Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation
Array CGH-based analysis of post-transplant plasmacytic hyperplasia reveals ‘intact genomes’ arguing against categorizing it as part of the post-transplant lymphoproliferative disease spectrum
Total hepatectomy, pancreatoduodenectomy, and living donor liver transplantation using innovative vascular reconstruction for unresectable cholangiocarcinoma
ABO incompatible kidney transplantation from an anti-hepatitis C virus antibody-positive RNA-negative donor into an anti-hepatitis C virus antibody-negative recipient
A staged approach for a lung–liver transplant patient using ex vivo reconditioned lungs first followed by an urgent liver transplantation